Regentis Biomaterials Ltd. (RGNT)
RGNT trades on NYSE in Health Care, Industrial Specialties. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | RGNT on NYSE |
| Sector | Health Care |
| Industry | Industrial Specialties |
| Country | Israel |
| IPO year | 2025 |
| SEC CIK | 0001912966 |
| SEC industry code | Orthopedic, Prosthetic & Surgical Appliances & Supplies |
| Incorporated in | Israel |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "Such conditions raise substantial doubts about our ability to continue as a going concern." | 20-F 2026-02-24 |
| Cash and burn | $7.4M cash; operating cash flow -$344K a quarter. | Report 2025-12-31 |
| Shares outstanding | 5,179,378 (2025-12-31). the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Brightman Almagor Zohar & Co., Tel Aviv, Israel | PCAOB Form AP 2026-03-22 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | Not filed | -$13.6M | -$1.4M | $7.4M | $1.2M | Needs four quarters | 20-F/A 2026-02-27 |
| FY 2024 2024-12-31 | Not filed | $4.8M | -$641K | Not filed | $4.9M | Needs four quarters | 20-F/A 2026-02-27 |
| FY 2023 2023-12-31 | Not filed | -$4.1M | -$1.2M | Not filed | $210K | Needs four quarters | 20-F/A 2026-02-27 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | POS AM | 2026-09-17 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-02-24 |
| Latest quarterly / interim | 6-K | 2026-11-09 |
Source: SEC EDGAR submissions feed, 94 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +3.4% |
| 1 month | -24.3% |
| 3 months | -35.3% |
| Year to date | -81.8% |
| 1 year | Not enough price history |
| From 52-week high | -86.9% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Industrial Specialties
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HSCS | HeartSciences Inc. | $2.08 | -2.12% | $10.1M |
| FGI | FGI Industries Ltd. | $5.23 | -16.98% | $10.1M |
| LFWD | Lifeward Ltd. | $3.62 | -9.88% | $10.3M |
| CUPR | Cuprina Holdings (Cayman) Limited | $1.68 | -0.59% | $12.9M |
| TLIH | Ten-League International Holdings Limited | $5.80 | +1.05% | $17.1M |
| MLSS | Milestone Scientific Inc. | $0.2940 | -4.23% | $26.6M |
| MAMO | Massimo Group | $0.9301 | -4.59% | $38.7M |
| MYO | Myomo Inc. | $1.02 | -17.07% | $40.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier